NEURODERMATITIS
Clinical trials for NEURODERMATITIS explained in plain language.
Never miss a new study
Get alerted when new NEURODERMATITIS trials appear
Sign up with your email to follow new studies for NEURODERMATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New injection shows promise for relieving debilitating skin itch
Disease control CompletedThis study tested whether an injectable medication called dupilumab could reduce severe itch and improve skin lesions in adults with prurigo nodularis, a chronic skin condition. Participants had tried but were not helped by standard prescription creams. The 24-week trial compared…
Matched conditions: NEURODERMATITIS
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
New injection shows promise for debilitating skin itch
Disease control CompletedThis study tested whether dupilumab, an injectable medication, could help adults with prurigo nodularis, a skin condition causing intense itch and thick bumps. The trial involved 151 people whose condition was not controlled by standard prescription creams. Participants received …
Matched conditions: NEURODERMATITIS
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Shockwaves target unbearable skin itch
Symptom relief CompletedThis study tested whether shockwave therapy could reduce severe itching in people with neurodermatitis, a chronic skin condition. Researchers enrolled 34 patients aged 55-75 to receive the non-invasive treatment. The goal was to see if this approach could provide relief where con…
Matched conditions: NEURODERMATITIS
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated Mar 30, 2026 14:31 UTC